

Publisher: Adis International
ISSN: 1173-5503
Source: PharmacoEconomics and Outcomes News, Vol.1, Iss.667, 2012-01, pp. : 4-4
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content


Reference pricing or HTA for obtaining best value from drugs?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 540, 2007-01 ,pp. :


Paediatric rule needed in Europe?
Inpharma, Vol. 1, Iss. 1236, 2000-01 ,pp. :


Inpharma, Vol. 1, Iss. 1618, 2007-01 ,pp. :


Prevention of Schizophrenia: Can it Be Achieved?
By Cheng Lee Thomas H. McGlashan Scott W. Woods
CNS Drugs, Vol. 19, Iss. 3, 2005-01 ,pp. :


Pioglitazone the answer to managing type 2 DM in Europe?
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 343, 2001-01 ,pp. :